Skip to main content
PBF logo

PBF — Investor Relations & Filings

Ticker · 1760 ISIN · TW0001760007 LEI · 54930078VUU2LBPR2729 TW Manufacturing
Open in API
Filings indexed 1,562 across all filing types
Latest filing 2022-10-07 Regulatory Filings
Country TW Taiwan
Listing TW 1760

About PBF

http://www.pbf.com.tw

Panion & BF Biotech Inc. is a biotechnology company focused on pharmaceutical research, development, and manufacturing. Founded in 1976, the firm operates across several core sectors, including new drug innovation, medical aesthetics, and nutritional supplements. It is recognized for its "Total Aging Management" strategy, which addresses the health needs of an aging population through a diverse product portfolio. Key offerings include treatments for chronic kidney disease, specifically phosphate binders, as well as dermatological drugs, hair care solutions, and rapid diagnostic technologies. The company integrates clinical-grade pharmaceutical standards into its consumer health and aesthetic products, serving markets in chronic disease care and preventative wellness.

Recent filings

Filing Released Lang Actions
111年9月背書保證與資金貸與
Regulatory Filings Classification · 95% confidence The document is a brief financial disclosure from a listed company, providing data on loan balances and guarantee information for the current and previous months. It is very short (613 characters) and contains tabular financial data but no comprehensive financial statements or detailed analysis. It does not appear to be a full financial report like an Annual Report (10-K) or Interim Report (IR). Instead, it is a regulatory disclosure of specific financial information, likely a routine regulatory filing. There is no indication of a meeting, voting results, or management changes. The content fits best under Regulatory Filings (RNS) as a general regulatory announcement of financial data that does not fit other categories.
2022-10-07 Chinese
111年9月營業收入
Interim / Quarterly Report Classification · 95% confidence The document is a summarized revenue report from a listed company, showing monthly and cumulative net operating revenue figures with percentage changes compared to the previous year. It includes notes on accounting standards (IFRS) and reporting practices. The document length is short (775 characters) and it primarily provides financial data for a specific month and year (September 2022, 民國111年09月). This matches the characteristics of an Interim / Quarterly Report (IR), which contains substantive financial data for a period shorter than a full fiscal year. It is not an announcement of a report, nor a certification or a brief summary, but actual financial figures and analysis are present. Therefore, the correct classification is IR with high confidence. 9M 2022
2022-10-07 Chinese
公告董事會授權董事長申購基金 STI Power fund(補充公告)
Capital/Financing Update Classification · 95% confidence The document is a company announcement regarding the board's authorization for the chairman to purchase a fund (STI Power fund). It details the transaction specifics such as the fund name, transaction amount, unit price, decision process, and related compliance information. The document is short (2057 characters) and focuses on a specific capital transaction rather than a financial report or earnings release. It does not contain financial statements or management discussion but is an update on a financing-related activity (purchase of investment units). Therefore, it fits best under Capital/Financing Update (CAP).
2022-09-27 Chinese
111年08月內部人持股異動(事後)
Director's Dealing Classification · 95% confidence The document contains detailed tables listing shareholdings and changes in share ownership by company insiders, including directors, managers, and their related parties. It shows specific share counts, increases, decreases, and trust holdings. The content focuses on insider share transactions and holdings rather than financial results, management changes, or other corporate events. There is no indication of it being a full financial report, earnings release, or regulatory announcement. The document is a report of personal share transactions by company directors and executives (insider trades). Therefore, it fits the category of Director's Dealing (DIRS).
2022-09-14 Chinese
111年08月董事會成員及持股
Director's Dealing Classification · 100% confidence The document is a detailed tabulation of shareholdings by insiders, including directors, supervisors, and executives, showing their current holdings, pledged shares, and related percentages. It lists individual names, titles, and share counts, focusing on insider share transactions or holdings. There is no indication of financial results, earnings, management discussion, or regulatory announcements. The document is not a report or announcement of a meeting or vote, nor is it a certification or legal proceeding. The content matches the definition of a Director's Dealing report, which reports personal share transactions or holdings by company directors and executives.
2022-09-14 Chinese
111年8月背書保證與資金貸與
Regulatory Filings Classification · 95% confidence The document is a brief financial disclosure from a listed company, providing data on fund lending balances and endorsement guarantees for the current and previous months, including limits. It is very short (613 characters) and contains tabular financial data but no comprehensive financial statements or detailed analysis. It appears to be a regulatory disclosure of specific financial information rather than a full report or announcement of a report. There is no indication of an annual or interim report, audit report, or earnings release. The content fits best as a Regulatory Filing (RNS) because it is a general regulatory announcement of financial data that does not fit other specific categories.
2022-09-08 Chinese

Browse filings by year

14 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.